PL2215047T3 - Sposób leczenia niedoborów witaminy b12 - Google Patents

Sposób leczenia niedoborów witaminy b12

Info

Publication number
PL2215047T3
PL2215047T3 PL08844673T PL08844673T PL2215047T3 PL 2215047 T3 PL2215047 T3 PL 2215047T3 PL 08844673 T PL08844673 T PL 08844673T PL 08844673 T PL08844673 T PL 08844673T PL 2215047 T3 PL2215047 T3 PL 2215047T3
Authority
PL
Poland
Prior art keywords
deficiency
treating vitamin
vitamin
treating
Prior art date
Application number
PL08844673T
Other languages
English (en)
Inventor
Cristina Castelli
Laura Kragie
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2215047(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of PL2215047T3 publication Critical patent/PL2215047T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08844673T 2007-11-02 2008-10-31 Sposób leczenia niedoborów witaminy b12 PL2215047T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US98489807P 2007-11-02 2007-11-02
US2010808P 2008-01-09 2008-01-09
US8356608P 2008-07-25 2008-07-25
EP08844673.7A EP2215047B1 (en) 2007-11-02 2008-10-31 Method of treating vitamin b12 deficiency
PCT/US2008/082064 WO2009059188A1 (en) 2007-11-02 2008-10-31 Method of treating vitamin b12 deficiency

Publications (1)

Publication Number Publication Date
PL2215047T3 true PL2215047T3 (pl) 2014-05-30

Family

ID=40591491

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08844673T PL2215047T3 (pl) 2007-11-02 2008-10-31 Sposób leczenia niedoborów witaminy b12

Country Status (18)

Country Link
US (3) US8022048B2 (pl)
EP (1) EP2215047B1 (pl)
JP (1) JP5555634B2 (pl)
KR (1) KR101344369B1 (pl)
CN (1) CN101952241B (pl)
AU (1) AU2008318423B2 (pl)
BR (1) BRPI0817396C8 (pl)
CA (1) CA2704780C (pl)
CL (1) CL2010000434A1 (pl)
CO (1) CO6280475A2 (pl)
DK (1) DK2215047T3 (pl)
ES (1) ES2443817T3 (pl)
MX (1) MX2010004716A (pl)
NZ (1) NZ585080A (pl)
PL (1) PL2215047T3 (pl)
PT (1) PT2215047E (pl)
RU (1) RU2469728C2 (pl)
WO (1) WO2009059188A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011017346A2 (en) * 2009-08-03 2011-02-10 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
AR080292A1 (es) * 2010-02-24 2012-03-28 Emisphere Tech Inc Metodo para normalizar en forma rapida los niveles de vitamina b12 en un paciente que tiene deficiencia de vitamina b12 y un nivel promedio de vitamina b12 por debajo de 350 pg/ml
HRP20180425T1 (hr) 2010-12-16 2018-04-20 Novo Nordisk A/S Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
BR112013026195A2 (pt) 2011-04-12 2016-11-29 Novo Nordisk As derivados de glp-1 duplamente acilados
US8805208B2 (en) * 2012-02-03 2014-08-12 Tyco Electronics Subsea Communications Llc System and method for polarization de-multiplexing in a coherent optical receiver
SMT201800491T1 (it) 2012-03-22 2018-11-09 Novo Nordisk As Composizioni di peptidi glp-1 e relativa preparazione
PT2827845T (pt) 2012-03-22 2019-03-29 Novo Nordisk As Composições compreendendo um agente de entrega e sua preparação
WO2013139695A1 (en) 2012-03-22 2013-09-26 Novo Nordisk A/S Compositions comprising a delivery agent and preparation thereof
JP6517690B2 (ja) 2012-06-20 2019-05-22 ノヴォ ノルディスク アー／エス ペプチド及び送達剤を含む錠剤製剤
US9211284B2 (en) 2013-04-11 2015-12-15 Richard Louis Price Diagnosis and treatment of P.R.I.C.E. syndrome
US20170348417A1 (en) 2013-04-11 2017-12-07 Richard Louis Price Treatment of attention deficit disorders and associated symptoms
US20140309270A1 (en) 2013-04-11 2014-10-16 Richard Louis Price Diagnosis and treatment of a form of autistic spectrum disorder
US10098848B2 (en) 2013-04-11 2018-10-16 Richard Louis Price Inositol-containing comestible units and methods of treatment using the same
US9603812B2 (en) 2013-04-11 2017-03-28 Richard Louis Price Treatment of autistic spectrum disorder
ES2688462T3 (es) 2013-05-02 2018-11-02 Novo Nordisk A/S Dosificación oral de compuestos de GLP-1
CA3021660A1 (en) 2016-04-22 2017-10-26 Receptor Life Sciences, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
CA3078180A1 (en) * 2017-10-05 2019-04-11 Receptor Holdings, Inc. Herbal compositions with improved bioavailability
CN111225678A (zh) * 2017-10-05 2020-06-02 受体控股公司 快速起效且延长作用的植物类及合成大麻素制剂
EP3746111B1 (en) 2018-02-02 2023-07-19 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant
CA3120001A1 (en) 2018-11-19 2020-05-28 Receptor Holdings, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
CA2266412A1 (en) * 1996-09-18 1998-03-26 William J. Sarill Compositions containing cobalamin and amino acids
US5773647A (en) 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2000038696A1 (en) * 1998-12-28 2000-07-06 Allergy Limited, Llc Cyanocobalamin (vitamin b12) treatment in allergic disease
EP1535625B1 (en) 1999-04-05 2014-01-08 Novartis AG Composition containing n-(5-chlorosalicyloyl)-8-aminocaprylic acid and salmon calcitonin
CA2369591C (en) 1999-04-05 2011-06-14 Emisphere Technologies, Inc. Disodium salts, monohydrate, and ethanol solvates
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
US7049283B2 (en) 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
NZ529439A (en) 2001-06-01 2005-11-25 Novartis Ag Method for orally administering parathyroid hormone (PTH)
PT1420827E (pt) 2001-08-17 2009-12-15 Novartis Ag 5-cnac como agente de administração oral de fragmentos da hormona paratiróide
US20050054557A1 (en) 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin
TW200403052A (en) 2002-07-17 2004-03-01 Novartis Ag Use of organic compounds
TWI307279B (en) 2002-08-01 2009-03-11 Novartis Ag Oral administration of calcitonin
AU2003275329B2 (en) * 2002-09-13 2008-04-03 Cydex Pharmaceuticals, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
CN100579955C (zh) 2003-04-04 2010-01-13 帝斯曼知识产权资产管理有限公司 N-烷氧基草酰丙氨酸酯的制备方法
US6938439B2 (en) 2003-05-22 2005-09-06 Cool Clean Technologies, Inc. System for use of land fills and recyclable materials
JP3924616B2 (ja) 2003-06-30 2007-06-06 独立行政法人物質・材料研究機構 微小サイズの温度感知素子を用いる温度計測方法
CN1816324A (zh) 2003-07-04 2006-08-09 尼克麦德丹麦公司 口服用的含甲状旁腺激素(pth)的药物组合物
AU2004255458B2 (en) 2003-07-11 2007-09-13 Emisphere Technologies, Inc. Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
BRPI0412265A (pt) 2003-07-23 2006-09-05 Novartis Ag uso de calcitonina em osteoartrite
US8636996B2 (en) * 2004-05-06 2014-01-28 Emisphere Technologies, Inc Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
MX2007001348A (es) * 2004-08-02 2008-03-11 Bebaas Inc Composiciones de vitamina b12.
US20060078623A1 (en) 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US20060116334A1 (en) * 2004-12-01 2006-06-01 Curt Hendrix Folate based composition for treatment of the cardiovascular system
GB0427600D0 (en) 2004-12-16 2005-01-19 Novartis Ag Organic compounds
GB0427603D0 (en) 2004-12-16 2005-01-19 Novartis Ag Organic compounds
ZA200803283B (en) 2005-11-04 2009-11-25 Genta Inc Pharmaceutical gallium compositions and methods

Also Published As

Publication number Publication date
BRPI0817396A2 (pt) 2015-04-07
EP2215047A4 (en) 2010-11-10
RU2469728C2 (ru) 2012-12-20
DK2215047T3 (da) 2014-02-03
EP2215047B1 (en) 2013-11-20
US8557792B2 (en) 2013-10-15
CL2010000434A1 (es) 2011-01-28
US20100016255A1 (en) 2010-01-21
JP2011502997A (ja) 2011-01-27
CN101952241A (zh) 2011-01-19
AU2008318423A1 (en) 2009-05-07
CN101952241B (zh) 2014-06-11
BRPI0817396B8 (pt) 2020-02-04
RU2010118423A (ru) 2011-12-10
CO6280475A2 (es) 2011-05-20
BRPI0817396B1 (pt) 2019-04-24
US20110293589A1 (en) 2011-12-01
US8022048B2 (en) 2011-09-20
ES2443817T3 (es) 2014-02-20
JP5555634B2 (ja) 2014-07-23
KR101344369B1 (ko) 2013-12-24
PT2215047E (pt) 2014-01-20
BRPI0817396C1 (pt) 2020-11-17
CA2704780A1 (en) 2009-05-07
US8288360B2 (en) 2012-10-16
EP2215047A1 (en) 2010-08-11
KR20100126263A (ko) 2010-12-01
AU2008318423B2 (en) 2013-12-05
WO2009059188A1 (en) 2009-05-07
CA2704780C (en) 2014-06-10
BRPI0817396C8 (pt) 2021-05-25
HK1146480A1 (en) 2011-06-10
US20130040910A1 (en) 2013-02-14
NZ585080A (en) 2012-05-25
MX2010004716A (es) 2010-12-17

Similar Documents

Publication Publication Date Title
PT2215047E (pt) Processo para o tratamento da deficiência de vitamina b12
PL2148684T3 (pl) Sposób leczenia niedoboru i deficytu witaminy D
IL257418A (en) Methods for treating addiction
IL212348A0 (en) Treatment method
EP2313103A4 (en) PROCESS FOR TREATING A BLÉPHARITE
IL227641A0 (en) Methods for treating arthritis
ZA201707693B (en) Vitamin d3 and analogs thereof for treating alopecia
EP2148685A4 (en) METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
PL2301893T3 (pl) Sposób oczyszczania ścieku
IL200499A0 (en) Stabilization of vitamin b12
EP2144504A4 (en) METHOD FOR COMBATING BRAIN CANCER
EP2350641A4 (en) Methods of Treatment
IL200769A (en) A method for processing potash
IL238394A0 (en) Cancer treatment method
PT2393758E (pt) Processo de tratamento de águas residuais
GB0718684D0 (en) Treatment method
EP2144886A4 (en) METHOD OF TREATING MELANOMA
EP2164515A4 (en) PROCESS FOR TREATING ATOPIC ECZEMA
PT2509599E (pt) Processo para o tratamento de cancro pancreático
EP2203432A4 (en) PROCESSING METHOD
GB0723972D0 (en) Use of vitamin B12
GB0717337D0 (en) Method of treatment
GB0711228D0 (en) Treatment method
ZA201102198B (en) Treatment method
GB0823435D0 (en) Method of treatment